Morgan Stanley’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Sell |
195,494
-80,558
| -29% | -$614K | ﹤0.01% | 4890 |
|
|
2025
Q1 | $900K | Sell |
276,052
-2,143
| -0.8% | -$6.99K | ﹤0.01% | 5051 |
|
|
2024
Q4 | $1.25M | Buy |
278,195
+6,763
| +2% | +$30.4K | ﹤0.01% | 4974 |
|
|
2024
Q3 | $752K | Sell |
271,432
-67,761
| -20% | -$188K | ﹤0.01% | 5204 |
|
|
2024
Q2 | $1.16M | Buy |
339,193
+257,974
| +318% | +$882K | ﹤0.01% | 4870 |
|
|
2024
Q1 | $440K | Buy |
81,219
+57,391
| +241% | +$311K | ﹤0.01% | 5372 |
|
|
2023
Q4 | $129K | Buy |
23,828
+6,364
| +36% | +$34.5K | ﹤0.01% | 6079 |
|
|
2023
Q3 | $154K | Buy |
+17,464
| New | +$154K | ﹤0.01% | 5698 |
|